# US 2026/0060992 A1 · Compositions for overcoming tetracycline antibiotic resistance and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0060992 A1
- Document ID: US20260060992A1
- Status: Published application
- Kind: A1
- Application number: 19/313,798
- Filed: 2025-08-28
- Published: 2026-03-05
- Earliest claimed: 2024-08-28
- Assignees: Washington University; The United States of America, as represented by the Secretary, Department of Health and Human Servic
- Applicants: Washington University; The United States of America, as Represented by the Secretary, Department of Health and Human Servic
- Inventors: Timothy Wencewicz; Gautam Dantas; Niraj Tolia; Emily Williford; Kevin Blake; Yao-Peng Xue; Wai Kwan Tang
- Web page: https://patentgrep.com/patent/US20260060992A1

## CPC

- A61K 31/65: Tetracyclines
- A61P 31/04: Antibacterial agents
- C12N 9/99: Enzyme inactivation by chemical treatment
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Compositions for overcoming tetracycline antibiotic resistance and methods of use thereof are provided. Compositions include at least one compound selected from Formula (I) and Formula (II) as disclosed herein. Methods of treating a subject having a bacterial infection include administering at least one compound selected from Formula (I) and Formula (II) as disclosed herein. In some embodiments, the composition further includes at least one tetracycline antibiotic.

## Claims

### Claim 1

A composition comprising at least one compound selected from

### Claim 2 (depends on 1)

The composition of claim 1, wherein R is selected from:

### Claim 3 (depends on 1)

The composition of claim 1, further comprising a tetracycline antibiotic.

### Claim 4

A composition comprising at least one compound according to

### Claim 5 (depends on 4)

The composition of claim 4, wherein R is selected from:

### Claim 6 (depends on 4)

The composition of claim 4, further comprising a tetracycline antibiotic.

### Claim 7

A method of treating a bacterial infection in a subject in need thereof, the method comprising:
administering to the subject a therapeutically effective amount of a composition comprising at least one compound selected from a C10-benzoate and a C9-benzamide.

### Claim 8 (depends on 7)

The method of claim 7, wherein the C10-benzoate comprises

### Claim 9 (depends on 8)

The method of claim 8, wherein R of Formula (I) is selected from:

### Claim 10 (depends on 8)

The method of claim 8, wherein the composition further comprises a tetracycline antibiotic.

### Claim 11 (depends on 8)

The method of claim 8, wherein the bacterial infection is caused by a bacterial pathogen selected from Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Legionella longbeacha, and Mycobacteria abscessus.

### Claim 12 (depends on 8)

The method of claim 8, wherein Formula (I) has antibacterial activity.

### Claim 13 (depends on 8)

The method of claim 8, wherein the composition inhibits one or more tetracycline destructase enzymes.

### Claim 14 (depends on 7)

The method of claim 7, wherein the C9-benzmide comprises

### Claim 15 (depends on 14)

The method of claim 14, wherein R of Formula (II) is selected from:

### Claim 16 (depends on 14)

The method of claim 14, wherein the composition further comprises a tetracycline antibiotic.

### Claim 17 (depends on 14)

The method of claim 14, wherein the bacterial infection is caused by a bacterial pathogen selected from Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Legionella longbeacha, and Mycobacteria abscessus.

### Claim 18 (depends on 14)

The method of claim 14, wherein Formula (II) has antibacterial activity.

### Claim 19 (depends on 14)

The method of claim 14, wherein the composition inhibits one or more tetracycline destructase enzymes.
